TickerFacts.

Black Diamond Therapeutics, Inc. (BDTX): Net Income

Annual figures by period end, from SEC filings.

$22.37M
Year ended 2025-12-31
-$42.55M
Trailing 12 months to 2026-06-30
2018-12-31: -$8.93M2019-12-31: -$35.26M2020-12-31: -$67.25M2021-12-31: -$125.60M2022-12-31: -$91.17M2023-12-31: -$82.44M2024-12-31: -$69.68M2025-12-31: $22.37M$22.37M
2018-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$22.37Mn/m2026-03-16, From 2025-01-01
2024-12-31-$69.68Mn/m2026-03-16, From 2024-01-01
2023-12-31-$82.44Mn/m2025-03-06, From 2023-01-01
2022-12-31-$91.17Mn/m2024-03-12, From 2022-01-01
2021-12-31-$125.60Mn/m2023-03-09, From 2021-01-01
2020-12-31-$67.25Mn/m2022-03-17, From 2020-01-01
2019-12-31-$35.26Mn/m2021-03-25, From 2019-01-01
2018-12-31-$8.93Mn/a2020-03-24, From 2018-01-01

Net Income at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Black Diamond Therapeutics, Inc. (BDTX)2025-12-31$22.37Mn/m
Vir Biotechnology, Inc. (VIR)2025-12-31-$437.99Mn/m
Compugen Ltd (CGEN)2025-12-31$35.34Mn/m
Recursion Pharmaceuticals, Inc. (RXRX)2025-12-31-$644.76Mn/m
Autolus Therapeutics plc (AUTL)2025-12-31-$287.53Mn/m
MeiraGTx Holdings plc (MGTX)2025-12-31-$114.20Mn/m
Champions Oncology, Inc. (CSBR)2026-04-30-$1.18Mn/m
4D Molecular Therapeutics, Inc. (FDMT)2025-12-31-$140.11Mn/m
Invivyd, Inc. (IVVD)2025-12-31-$52.49Mn/m

Compare BDTX, VIR, CGEN, RXRX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗